Sir, We are writing this letter to enlighten the readers of this journal about a novel and somewhat unresearched phenomenon with potential therapeutic applications.
Its name is Autonomous Sensor y Meridian Response (ASMR).
ASMR is a perceptual sensory phenomenon, likened to meditation, which encompasses a pleasant and calming "tingling" sensation localized to the scalp and neck in those able to experience it. [1] These sensations are triggered by specific auditory and visual stimuli such as whispering, personal attention, and even being the subject of a physician's clinical examination. [1] People looking to experience ASMR turn to the website "YouTube" where videos have been produced that utilize these triggers. These videos are generally watched by users in a quiet environment to achieve the relaxing effect of ASMR. [1] Numerous media outlets have reported on ASMR; however, this phenomenon is not very well understood and our attempts to research ASMR on the database "PubMed" only provides three results (at the time of writing this article).
One of these papers was by Ahuja who described how this phenomenon can be caused by being the subject of a clinician's physical examination and suggests that ASMR may contribute to the therapeutic effects of a routine clinician's assessment. [2] Another paper was by Smith et al. and attempted to discover some of the neural underpinnings of ASMR, suggesting that individuals who experience ASMR demonstrate an increased connectivity between certain brain regions in the occipital, frontal, and temporal cortices. [3] The most clinically relevant paper is a study of 475 people who experience ASMR published by Barratt and Davis who show that ASMR helps users relax, deal with stress, and get to sleep with greater ease. [1] The authors also show that ASMR elicits a positive effect on mood and causes a significant reduction in symptoms of chronic pain for several hours following an ASMR session. [1] Given the prevalence of sleep disorders, anxiety, and depression in this day and age, it is important to explore every possible avenue with regard to therapeutics. It is obvious that research on this topic is still in its infancy and that publications in the field are few and far between. We also appreciate the difficulty in researching a phenomenon that can only be experienced by a small proportion of people
Asymmetric, Tender Gynecomastia Induced by Olanzapine in a Young Male
Sir, Approximately 10-25% of the causes of gynecomastia are drug-induced. [1] Gynecomastia may result from imbalance in levels of androgen and estrogen as well as the elevated level of prolactin. [2] Drugs involving these hormone systems are likely to cause gynecomastia. Antipsychotic medications-induced hyperprolactinemia may manifest as gynecomastia. [3] Antipsychotic medications such as clozapine, olanzapine, aripiprazole, ziprasidone, and quetiapine possess prolactin-sparing property, hence the risk of gynecomastia with these medications is low. [3] [4] [5] The evidence for olanzapine-induced gynecomastia are scarce and limited to case reports.
A 20-year-old male had complaints of suspiciousness, fearfulness, increased physical activity, and decreased sleep for the last 1 week. These symptoms caused significant impairment in day to day functioning. This was the first episode of psychiatric illness. Physical examination of the patient did not reveal any abnormality. His routine blood investigations, thyroid function tests were within normal limits. He was diagnosed with acute and transient psychotic disorder and was started on olanzapine 10 mg/day and clonazepam 0.5 mg/day. The patient had shown improvement on the above treatment and his symptoms resolved completely in a month time. At 6 months follow-up visit, the patient reported painful enlargement of both breasts. The enlargement was asymmetrical; more in the left side than right. The patient did not report any other side effects commonly observed with olanzapine. The dose of olanzapine was reduced to 5 mg/day as the patient was clinical stable and acetaminophen 500 mg was prescribed for pain on as and when required. After 2 months of dose reduction, there was a significant improvement. The tenderness as well as enlargement of both breasts resolved completely. Causality assessment had been done using Naranjo adverse drug reaction probability scale which was suggestive of "probable adverse drug reaction" to olanzapine.
